These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3069643)

  • 41. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism.
    Rosenberg RD
    Am J Med; 1989 Sep; 87(3B):2S-9S. PubMed ID: 2679066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of complex formation and epidermal growth factor-like domains in the regulation of blood coagulation by the thrombomodulin-protein C system.
    Kurosawa S
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1343-9. PubMed ID: 2560886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Natural and synthetic inhibitors of thrombin. I. Natural inhibitors].
    Kibirev VK; Gershkovich AA
    Ukr Biokhim Zh (1999); 1999; 71(1):5-15. PubMed ID: 10457984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Protein C, protein S and heparin cofactor II--their significance as the regulatory factors in the blood coagulation cascade].
    Shinmyozu K
    Rinsho Byori; 1994 Jan; 42(1):9-15. PubMed ID: 8107289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
    Rosenberg RD
    Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombin: a new look at the actions of a serine protease inhibitor.
    Roemisch J; Gray E; Hoffmann JN; Wiedermann CJ
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):657-70. PubMed ID: 12441904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiological role of vessel wall related antithrombotic mechanisms: contribution of endogenous and exogenous heparin-like components to the anticoagulant potential of the endothelium.
    Preissner KT
    Haemostasis; 1990; 20 Suppl 1():30-49. PubMed ID: 2083871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Modern views of the role of heparin in hemostasis and regulation of enzymatic and hormonal activities].
    Kondashevskaia MV
    Vestn Ross Akad Med Nauk; 2010; (7):35-43. PubMed ID: 20795401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
    Jeske W; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interaction of blood and the vascular wall: hemostatic aspects].
    Gerlach E; Becker BF
    Z Kardiol; 1993; 82 Suppl 5():13-21. PubMed ID: 8154153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
    Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
    FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular Histones Bind Vascular Glycosaminoglycans and Inhibit the Anti-Inflammatory Function of Antithrombin.
    Biswas I; Panicker SR; Cai XS; Giri H; Rezaie AR
    Cell Physiol Biochem; 2021 Oct; 55(5):605-617. PubMed ID: 34655467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Significance of the endothelium of the vascular wall for maintaining hemostasis].
    Delvos U; Müller-Berghaus G
    Klin Wochenschr; 1985 Dec; 63(24):1237-46. PubMed ID: 3003450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential analytes for the diagnosis of thrombosis. An overview.
    Mann KG
    Ann Epidemiol; 1992 Jul; 2(4):365-70. PubMed ID: 1342287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: evaluation by an amidolytic assay.
    Heyderman RS; Klein NJ; Shennan GI; Levin M
    Thromb Res; 1992 Sep; 67(6):677-85. PubMed ID: 1440532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.